The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database
- 2 September 2016
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 27 (10) , 1261-1271
Abstract
Purpose Previous studies assessing racial and ethnic differences in ovarian cancer (OVCA) diagnosis stage fail to present subtype-specific results and provide historic data on cases diagnosed between 10 and 20 years ago. The purpose of this analysis is to assess non-Hispanic Black (NHB) and non-Hispanic White (NHW) differences in late-stage diagnosis including; (1) factors associated with late-stage diagnosis of invasive epithelial OVCA overall and by histologic subtypes, (2) potential changes across time and (3) current patterns of trends in a national cancer registry in the USA and Puerto Rico between 1998 and 2011. Methods NHB and NHW OVCA cases were derived from the National Cancer Database (NCDB). Diagnosis stage was analyzed as a dichotomous and a four level-category variable, respectively; early (stages I and II; localized) versus late (stages III and IV; regional and distant) and stages I, II, III and IV. Diagnosis period was trichotomized (1998–2002, 2003–2007, 2008–2011). Racial differences in stage were tested using Chi-square statistics. Odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated using multivariable binomial and generalized ordered logistic regressions. Interactions between race and diagnosis period were evaluated. Results Between 1998 and 2011, 11,562 (7.8 %) NHB and 137,106 (92.2 %) NHW were diagnosed with OVCA. In adjusted models, NHB were significantly more likely diagnosed with late-stage OVCA than NHW (ORadj 1.26, 95 % CI 1.19–1.33). Interaction between race and diagnosis period was marginally significant (p value = 0.09), with racial differences in stage decreasing over time (1998–2002: ORadj 1.36, 95 % CI 1.23–1.49; 2003–2007: ORadj 1.27, 95 % CI 1.15–1.39; 2008–2011; ORadj 1.15, 95 % CI 1.05–1.27). NHB were also more likely to be diagnosed with stage 4 high-grade serous (ORadj 1.46, 95 % CI 1.22–1.74), clear cell (ORadj 2.71, 95 % CI 1.94–3.79) and mucinous (ORadj 2.78, 95 % CI 2.24–3.46) carcinomas than NHW. Conclusions Racial differences in late-stage OVCA diagnosis exist; however, these differences are decreasing with time. Within NCDB, NHB are significantly more likely diagnosed with late-stage OVCA and more specifically high-grade serous, clear cell and mucinous carcinomas than NHW.Keywords
Funding Information
- : American Cancer Society Research Scholar Grant (RSG-13-380-01-CPHPS)
- National Cancer Institute (NCI NIH R25CA057699)
- National Eye Institute (NIH/NEI EY01792 and Research to Prevent Blindness, Inc.)
This publication has 33 references indexed in Scilit:
- The impact of comorbidity on cancer survival: a reviewClinical Epidemiology, 2013
- Racial Disparities in Changing to a High-volume Urologist Among Men With Localized Prostate CancerMedical Care, 2011
- Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancersBritish Journal of Cancer, 2011
- Racial/Ethnic Discrimination in Health Care: Impact on Perceived Quality of CareJournal of General Internal Medicine, 2010
- The National Cancer Data Base: Past, Present, and FutureAnnals of Surgical Oncology, 2009
- Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the NetherlandsGynecologic Oncology, 2009
- Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancerGynecologic Oncology, 2008
- Cancer communication patterns and the influence of patient characteristics: Disparities in information-giving and affective behaviorsPatient Education and Counseling, 2006
- Continuity of care and early diagnosis of head and neck cancerOral Oncology, 2006
- The Association Between Health Care Coverage and the Use of Cancer Screening TestsMedical Care, 1998